Investor Presentation • Aug 25, 2022
Investor Presentation
Open in ViewerOpens in native device viewer

Financial Review

This presentation does not constitute an offer to purchase the Company's securities or solicitation to receive such offers and is designed solely to offer information as part of the Company's explanations regarding its H1 2022 financial reports.
This presentation includes information regarding the Company's strategic plan for the years 2022-25 as well as forward-looking information as defined in section 32A of the Securities Law 5728-1968.
The realization and/or non-realization of forward-looking information which is stated in the financial reports and this presentation will be affected by risk factors that characterize the activities of the Company and group companies, as detailed in the Company's periodic reports, including changes in economic conditions, capital market in Israel and globally, the development of competition in the segments relevant to the group's activities, regulatory changes, changes in consumer preferences and consumption habits, changes in working assumptions or in the economic models and assumptions, and changes in implementation or execution – that can not be estimated in advance and may not be controlled by the Company. Hence, there is no certainty that the actual results and achievements of the Company in the future will be in accordance with these views and may differ, also substantially, from those presented in this presentation.
Furthermore, the presentation includes data and assessments based on external sources, the contents of which were not independently tested by the Company and therefore the Company is not responsible for their accuracy.
This presentation was drafted for the sake of convenience and needs to be reviewed along side with the Company's public reports, including 2022 Q2 Financial Statements, which contain the complete information about the Company, before making any decision to invest in the Company's securities.
This presentation may include information that is presented differently from the way it was presented in the company's official reports, some information may be presented and/or categorized and/or edited and/or segmented differently from the company's official past reports.
For the avoidance of doubt, the Company does not undertake to update or change the information contained in this presentation.



Financial Results
Segment Breakdown
Appendix
Glossary


Phoenix Holdings at a Glance

(1) As of August 22, 2022
(2) Five-year period (2017-21 end of year for AUM growth, H2/2017-H1/2022 for ROE)
(3) As of December 31, 2021, with transitional measures; includes events post report date of dividend distribution from Phoenix Insurance to Phoenix Holdings, raising Tier 2 capital, and real estate ("Phoeniclass") transfer
(4) Based on average yields over 3 years ended 30.06.2022 in the general plans: #1 out of 5 in Policies (1991-2003), #1 out of 5 in Pension, & #3 out of 10 in Provident Funds

8.1%
Macro trends: Continued GDP growth at 6.8% in Q2 (annualized); increased inflation and interest rates
Capital Markets: Increased volatility with declines in Q2
Continued AUM contributions despite market volatility
Innovation: Vibrant tech ecosystem, #1 startups per capital, #1 R&D investment as percent of GDP 1 , despite changing market conditions





Long-Term Yields (10Y) 5 Percent



1Israel Securities Authority
2Israel Central Bureau of Statistics
3 World Bank, current USD, 2021
4 Bank of Israel (2021 figure is an estimate), including life insurance, pension, and provident funds
5 Bloomberg (inflation for 2022 is actual 6 months not annualized; long-term yields based on Israel 10-year government bond, not CPI-linked for the past 12 months)



Income





(*) Reclassification, for details see Appendix
Notes: Additional Core Businesses includes Pension & Provident (previously held under the insurance company), Investment Services (formerly Financial Services, primarily Excellence), Agencies, and Gama. Investments include yields and variable management fees above / below real 3%. For the convenience of the presentation, the statutory tax rate in insurance and the core fee business is used, while the difference between the actual tax and the statutory tax is recorded in Special Items respectively. See Glossary for definition of Special Items.










Value Drivers
Growth Engines
Insurance
Asset Management
Distribution (Agencies & More)
Credit
Accelerated Growth
Accelerating growth while shifting mix to high-ROE, capital-efficient businesses (P&C, asset management, distribution)
1 2 3 4
Innovation & Efficiency
Deepening sustainable competitive advantage with 1 NISb investments in technology (data, digitization, products) during plan
Active Management
Optimizing group portfolio, management, structure, and synergies to unlock and create value


Deploying capital against strategic priorities, reducing volatility and ensuring long-term cashflow generation

Credit: 68% growth in Gama credit portfolio






target


• Continued strategic execution toward targets
• Dynamic management of interest and capital markets exposure for risk-adjusted returns
Note: Mid-term Targets based on 5-year plan 2020-25 and assuming 3% return on investments. ROE target range assumes 3-5% return on Nostro investments. Actual performance will depend on financial | 14 markets, macroeconomic growth, industry trends, company performance and other variables


| P&C | Expense | Ratios2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Premiums NISb |
Including growth of Smart direct | |||||||||
| 4.2-4.8 | P&C | Health | Life | |||||||
| 3.2 | 2019 | 4.10% | 5.57% | 0.50% | ||||||
| 2.9 | 2.0 1.6 |
2020 | 5.08% | 5.82% | 0.49% | |||||
| 2021 | 4.40% | 5.50% | 0.41% | |||||||
| H1/22 | 3.71% | 5.12% | 0.40% | |||||||
| 3.4-3.7% | 5.4-5.8% | 0.27-0.30% | Mid-term target (2025) | |||||||
| 2020 | 2021 | H1/21 | H1/22 | mid term target (2025) |
3.2 premiums |
2.7 premiums |
97 AUM |
Base 2021 (NISb) | ||
| Solvency | 1 | Comprehensive Income | ||||||||
| Ratio | NISm | 3% real returns, without special items, after tax | ||||||||
| 192% | 190% | 739 | ||||||||
| 150-170% | 504 | 418 | ||||||||
| 330 | 284 | |||||||||
| 2020 | 2021 | Solvency target | 2020 | 2021 | H1/21 H1/22 |
mid-term |
1 Solvency ratio with transitional measures; target range based on reduced transitional measures over time
2 Expenses as percent of gross earned premiums (P&C and Health) and AUMs (Life); expenses include general and administrative expenses, as well as other expenses; Health mid-term targets without HMO activity Note: Mid-term Targets based on 5-year plan 2020-25 and assuming 3% real return on investments

target (2025)





Note: Mid-term Targets based on 5-year plan 2020-25 and assuming 3% return on investments
Growth, Income, & Resilience: Quality Businesses



Segment Breakdown
Appendix
Glossary



Comprehensive income before tax 2022 H1, NISm
925 NISm income from operations



Comprehensive income before tax 2022 Q2, NISm


P&C Health Life
Other Equity Returns Pension and provident

Comprehensive income before tax 2022 H1, NISm

Additional core businesses contributed 408 NISm out of 739 NISm income before tax
Q2 Income by Segment
Comprehensive income before tax 2022 Q2, NISm
• 7.9% ROE
Capital

Additional core businesses contributed 277 NISm, driving group income for the quarter
| 22

| Phoenix Holdings NISm | 31/12/2021 | 30/06/2021 | 30/06/2022 | Difference 12/21-6/22 |
|---|---|---|---|---|
| Cash | 2,154 | 2,105 | 2,459 | 305 |
| Intangible Assets | 2,775 | 2,655 | 2,919 | 144 |
| Deferred acquisition costs | 2,011 | 1,870 | 2,281 | 270 |
| Investments in associates | 1,346 | 576 | 1,474 | 128 |
| Investment property - other | 1,125 | 1,061 | 1,038 | -87 |
| Credit for purchase of securities | 2,550 | 2,284 | 3,208 | 658 |
| Other Assets | 5,804 | 7,328 | 6,933 | 1,129 |
| Other Financial Investments | 28,698 | 27,654 | 30,580 | 1,882 |
| Assets for yield-dependent contracts | 97,117 | 87,343 | 95,217 | -1,900 |
| Total Assets | 143,580 | 132,876 | 146,109 | 2,529 |
| Financial liabilities | 8,813 | 8,814 | 13,432 | 4,619 |
| Liabilities in respect of non-yield-dependent insurance contracts and investments contracts Liabilities in respect of yield-dependent |
25,113 | 24,297 | 25,316 | 203 |
| insurance contracts and investments contracts | 95,629 | 86,163 | 93,115 | -2,514 |
| Other Liabilities | 4,102 | 4,668 | 4,184 | 82 |
| Total equity | 9,923 | 8,934 | 10,062 | 139 |
| Total equity and liabilities | 143,580 | 132,876 | 146,109 | 2,529 |


Financial Results
Appendix
Glossary



Life Investment Other Services Other Equity Pension Provident Health Agencies Credit P&C

• Negative contribution of P&C due to impact of capital market returns
| Underwriting Profit | Q1 | Q2 | H1 |
|---|---|---|---|
| Compulsory Motor | 10 | 35 | 44 |
| Motor Property | -64 | -35 | -96 |
| Property & Other | 37 | 31 | 68 |
| Liability | 19 | 42 | 61 |
| Total | 2 | 73 | 77 |
(*) Reclassification, for details see Appendix.
Note: The underwriting profit assume a real rate of return of 3%, investment income includes income from corporate account (Nostro) above or below a 3% real return



(*) Reclassification, for details see Appendix.
Note:The underwriting profit assume a real rate of return of 3%, investment income includes income from own (Nostro) investments above or below a 3% real return. LAT interest - Including all changes in interest rate and excess non-marketable assets in LAT only | 26
(*)
(*)







• Negative impact of financial market declines • Financial margin increase due to CPI index changes
compared to 2021








Q2/2022
Q2/2021
Diff 44
34
10

80
(3)
83 124
31
93





future


| 32


| (9) | ||||||
|---|---|---|---|---|---|---|
| 20 | 11 | |||||
| Financial Margin |
Subsidiaries | Other | Special Items | 1-6/22 | ||
| 1-6/2021 | 11 | (1) | (8) | - | 2 | |
| Diff | 9 | 1 | (1) | - | 9 | |
| Q2/2022 | 12 | - | (4) | - | 8 | |
| Q2/2021 | 2 | (1) | (6) | - | (5) | |
| Diff | 10 | 1 | 2 | - | 13 |


Financial Results
Segment Breakdown
Appendix
Glossary



Returns - Insurance Nostro / Corporate Account Percent (nominal)

Asset Allocation - Insurance Nostro / Corporate Account Percent (Q2/22)

Strong demographic & wealth trends with high compulsory savings rates & potential for greater penetration
Leading diversified financial services group with over \$100b AUM (including multi-line insurance, asset management, credit, & distribution), delivering best-in-class 15% ROE and 18% AUM CAGR over the past 5 years
Significant share of income generated by recurring fee-based non-balance sheet businesses, with plan to unlock value of assets currently held at book value
Focus on accelerating growth in high ROE businesses, innovation and technology for competitive advantage and efficiency, active management of businesses to unlock & create value, & focused capital management / deployment
Consistent growth in shareholder equity with a Solvency ratio of 190% (with transitional measures) and 30% dividend distribution policy
Deep sector and broad functional experience at both board and management levels
5
1
2
3
4


Below is an explanation of reclassifications effecting the Health and P&C segments:
For consistency, comparative figures were reclassified as well
Below is a summary of the impact of the reclassification on 2021 income, showing the figures before and after reclassification:
| Comprehensive Income Before Tax | H1/2021 | Q2/2021 | 2021 | |||
|---|---|---|---|---|---|---|
| (NISm) | Before | After | Before | After | Before | After |
| Health | ||||||
| Underwriting | 77 | 117 | 42 | 74 | 168 | 250 |
| Investments | 46 | 7 | 10 | (12) | 123 | 41 |
| Special items | (50) | (51) | (30) | (40) | (152) | (152) |
| P&C | ||||||
| Underwriting | 180 | 172 | 108 | 102 | 285 | 277 |
| Interest | - | 8 | - | 6 | - | 8 |



Financial Results
Segment Breakdown
Appendix
Glossary



| AM | Asset Management; i.e. Excellence Nessuah |
|---|---|
| AUM | Assets Under Management; the total market value of all the investments that are managed by the Group |
| Bps | Basis Points; 1 basis points is .01% |
| CGU | Cost Generating Unit |
| CI | Comprehensive Income |
| CLR | Combined Loss Ratio |
| CO | Corporate, Other and Consolidation |
| CPI | Consumer Price Index; measures the average change of prices in an agreed upon basket of consumer goods and services over time |
| CSM | Contractual Service Margin |
| D&O | Directors and Officers Liability Insurance |
| DAC | Deferred Acquisition Cost |
| ESOP | Employee Stock Ownership Plan; workplace benefit program, that provides the employees with ownership interest in the company. |
| ETF | Exchange Traded Fund; an open end, tradable basket of securities that tracks an underling index, sector, or security type |
| Fixed-Rate Gov Bonds | A government issued bond for which the interest income payment is agreed upon and does not change |
| FX | Foreign Exchange Currency |
| Gama | Financial services and credit company owned by the Phoenix Group |
| Halman corporate funds | Israeli Electric Company (IEC) |
| Illiquidity Premium | Or Liquidity Premium; premium demanded by investors when any given security cannot be easily converted into cash for its fair market value. |
| IMF | International Monetary Fund |
| Index Linked Gov Bonds | A government issued bond for which the interest income payment is related (or linked) to the CPI |
| LAT | Liability Adequacy Test |
| Liquidity Premium | See Illiquidity Premium |
| LOB | Line of Business |
| LTC | Long Term Care insurance; typically helps pay for costs associated with long term care |
| LTS | Long Term Services; including but not limited to Life, Provident and Pension funds |
| Marketable Securities | Liquid financial assets that can be quickly converted into cash; most are trading assets |


| MF | Management Fees; wages charged by a financial manager |
|---|---|
| Moody's | A credit risk rating agency |
| MSCI | Morgan Stanley Capital International Emerging Markets Index; measures the performance in equity markets, specifically in global emerging markets |
| Mutual Fund | Open end, non-tradable basket of securities that tracks the performance of an undelaying index, sector, or security type |
| Net Inflows | The net amount of new cash, excluding the impact of investment market value; calculated by subtracting withdrawals from new deposits |
| NIS | New Israeli Shekel |
| Non-Marketable Securities | Asset group that is considered to be difficult to buy or sell due to the fact they are not traded on any major exchange; could include government issued debt securities, limited partnerships, real estate investments and more |
| Nostro | The account in which a financial institution manages its own funds |
| OPEX | Operational Expenses |
| P&C | Property and Casualty insurance |
| PH | Phoenix holdings |
| PHI | Permanent Health Insurance |
| PI | Phoenix insurance |
| PLI | Professional Liability insurance |
| Reinsurance | A balancing risk strategy; one or more insurers that share the liability |
| Revenue | All encompassing streams of income; including, but not limited to: premium, management fees, benefit contributions |
| RFR | Risk Free Rates |
| ROE | Return On Equity; calculated by dividing net income over total equity |
| SME60 | "The Rest Index"; tracks the performance of the 60 largest market value companies that are excluded from the Tel Aviv Stock Exchange |
| Special Items | Changes in profit or loss that are not part of the usual business of the Company, including changes in actuarial research, actuarial model changes, other structural changes and strategic acquisition costs in AM segment |
| Tel Bond 20 | Index that tracks the performance of the 20 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 40 | Index that tracks the performance of the 40 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 60 | Index that tracks the performance of the 60 largest Index linked Corporate Bonds in terms of market value |
| TLV 125 | An index that tracks the performance of the 125 largest market value companies in the Tel-Aviv Stock Exchange |
| TLV 35 | An index that tracks the performance of the 35 largest market value companies in the TLV Stock Exchange |
| TLV 90 | An index that tracks the performance of the 90 largest market value companies in the TLV stock Exchange |
| TMTP | Transitional Measures on Technical Provisions |
| Workers' Compensation Insurance | Insurance coverage for employees' injuries or sickness |
| Yield Curve | A line that plots interest rates of bonds with equal credit risk with different maturity dates in the future |


Financial Review
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.